The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease
- 15 November 2020
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 214 (5), 220-227
- https://doi.org/10.5694/mja2.50851
Abstract
Introduction Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) cause significant morbidity and premature mortality among Australian Aboriginal and Torres Strait Islander peoples. RHD Australia has produced a fully updated clinical guideline in response to new knowledge gained since the 2012 edition. The guideline aligns with major international ARF and RHD practice guidelines from the American Heart Association and World Heart Federation to ensure best practice. The GRADE system was used to assess the quality and strength of evidence where appropriate. Main recommendations The 2020 Australian guideline details best practice care for people with or at risk of ARF and RHD. It provides up‐to‐date guidance on primordial, primary and secondary prevention, diagnosis and management, preconception and perinatal management of women with RHD, culturally safe practice, provision of a trained and supported Aboriginal and Torres Strait Islander workforce, disease burden, RHD screening, control programs and new technologies. Changes in management as a result of the guideline Key changes include updating of ARF and RHD diagnostic criteria; change in secondary prophylaxis duration; improved pain management for intramuscular injections; and changes to antibiotic regimens for primary prevention. Other changes include an emphasis on provision of culturally appropriate care; updated burden of disease data using linked register and hospitalisations data; primordial prevention strategies to reduce streptococcal infection addressing household overcrowding and personal hygiene; recommendations for population‐based echocardiographic screening for RHD in select populations; expanded management guidance for women with RHD or ARF to cover contraception, antenatal, delivery and postnatal care, and to stratify pregnancy risks according to RHD severity; and a priority classification system for presence and severity of RHD to align with appropriate timing of follow‐up.Keywords
Funding Information
- National Heart Foundation of Australia
- National Health and Medical Research Council (1142011)
This publication has 30 references indexed in Scilit:
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive SummaryCirculation, 2014
- Group A Streptococcal Diseases and Their Global BurdenPublished by Springer Science and Business Media LLC ,2012
- World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guidelineNature Reviews Cardiology, 2012
- Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal PharyngitisCirculation, 2009
- Exploring the impact of an Aboriginal Health Worker on hospitalised Aboriginal experiences: lessons from cardiologyAustralian Health Review, 2009
- Apparent Contrasting Rates of Pharyngitis and Pyoderma in Regions where Rheumatic Heart Disease is Highly PrevalentHeart, Lung and Circulation, 2007
- Low Rates of Streptococcal Pharyngitis and High Rates of Pyoderma in Australian Aboriginal Communities Where Acute Rheumatic Fever Is HyperendemicClinical Infectious Diseases, 2006
- Acute rheumatic fever: a chink in the chain that links the heart to the throat?The Lancet Infectious Diseases, 2004
- The role of the streptococcus in the pathogenesis of rheumatic feverThe American Journal of Medicine, 1954
- PREVENTION OF RHEUMATIC FEVERJournal of the American Medical Association, 1950